Surveys

Regulatory Burden Remains a Material Drag on Healthcare Efficiency, with Physicians Feeling the Greatest Strain

Healthcare leaders consistently cite regulation as both a safeguard and a source of operational drag.

Margin Pressure Is No Longer a Sector Story. It Is a Business Model Story.

Biggest Cost Drivers in Healthcare

No Single Culprit — Layered Pressures Are Driving Costs Higher

Healthcare M&A Strategy Is Shifting Toward Discipline

Healthcare dealmaking hasn’t stopped — but the playbook is clearly evolving.

What Will Matter Most for Successful Healthcare M&A in This Cycle?

In a market defined by higher rates, tighter capital, and increased regulatory scrutiny, healthcare M&A is no longer just about finding the right asset — it’s about managing complexity after the deal closes

Where Healthcare M&A Is Most Likely to Hold Up in 2026

Healthcare dealmaking may be slower and more selective, but it’s far from stalled.

What Will Really Slow Healthcare M&A in the Next 12 Months?

Healthcare dealmaking isn’t short on capital—or targets. What it is short on is certainty.